Abstract
Cerebral small vessel disease (CSVD) poses major public health challenges, yet current MRI based diagnosis detects only established damage, and existing auxiliary methods, mostly based on conventional statistics, lack sufficient feature extraction capability and generalizability, thereby limiting early warning and precision management. Accordingly, we developed an intelligent auxiliary diagnostic system grounded in an interpretable ensemble learning framework, aiming to enable early detection and warning of CSVD. To support this development, a total of 597 sets of electronic medical record data from Quzhou Affiliated Hospital of Wenzhou Medical University were used as the study cohort. Firstly, a multidimensional feature evaluation and selection method was proposed, identifying 12 key predictive factors out of 23 relevant variables. Subsequently, the optimal algorithm was selected from Logistic Regression, Decision Tree, Random Forest, Support Vector Machine, Gradient Boosting Machine, XGBoost, and Multilayer Perceptron Classifier, based on Area Under the Curve (AUC) and Accuracy metrics, and a stacking ensemble learning strategy was then employed for model construction. The developed model demonstrated excellent discriminative performance, achieving an AUC of 0.881 while maintaining a low Brier score of 0.1271. By integrating the SHAP interpretability algorithm, the model provided intuitive visualizations of feature importance, thereby enhancing transparency and facilitating clinical adoption. Ultimately, this study achieved effective integration of early warning and auxiliary diagnostic functions for CSVD. These results indicate that the proposed system possesses high accuracy, interpretability, and deployability, underscoring its broad potential for early warning and personalized management of CSVD.
Similar content being viewed by others
Funding
This research was funded by National Natural Science Foundation of China under No. 52275268 and U23A6017, The Project about Building up “Scientists + Engineers” of Shaanxi Qinchuangyuan Platform under No. 2022KXJ-030, Xidian University Specially Funded Project for Interdisciplinary Exploration under No. TZJH2024025.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics statement
The studies involving human participants were reviewed by the Ethics Committee of the Quzhou Affiliated Hospital of Wenzhou Medical University and were exempt from ethical approval. Written informed consent for participation was not required for this study in accordance with national legislation and institutional requirements. The study of the test data adhered to the principles of the Declaration of Helsinki. The involvement of human subjects in this study was reviewed and approved by the Ethics Committee of the Quzhou Affiliated Hospital of Wenzhou Medical University ([2024] No. 040). In compliance with Chinese national legislation and institutional requirements, participants in the test data or their family members provided written or oral informed consent after receiving detailed information about the process, benefits, and risks of the experiment.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.

Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Wang, B., Yan, Y., Han, B. et al. An explainable ensemble learning-based auxiliary diagnosis system for cerebral small vessel disease. Sci Rep (2026). https://doi.org/10.1038/s41598-026-53171-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-026-53171-6


